The University of Texas MD Anderson Cancer Center applauds new actions announced today by the U.S. Food and Drug Administration (FDA) to limit the sale of most flavored electronic cigarettes (e-cigarettes) to age-restricted locations and require age-verification for online sales to lower the use of these products in children. In addition, the FDA plans to restrict the marketing of these products toward youth.
“Today's actions by...
For the first time, transplanting gut bacteria from healthy donors was used to successfully treat patients suffering from severe colitis caused...
A combination of the standard-of-care chemotherapy drug known as azacitidine, with nivolumab, an immune checkpoint inhibitor, demonstrated...
A Conversation With a Living Legend®, an annual luncheon benefiting The University of Texas MD Anderson Cancer Center, will pay tribute to the Honorable James A. Baker, III, the 61st U.S. secretary of state, 11:30 a.m.-1:30 p.m. Oct. 31 at the Marriott Rivercenter, 101 Bowie St.
Co-chairs Mary and Bob Worth and their children and their spouses, Clint and Jessica Worth, and Jordan and Brian Arriaga, of San Antonio, plan a dynamic...
Combination checkpoint blockade before surgery (neoadjuvant therapy) produced a high response rate among patients with high-risk stage 3 melanoma...
Jim Allison, Ph.D., chair of Immunology and executive director of the immunotherapy platform at The University of Texas...
A tumor-specific vaccine combined with an immune checkpoint inhibitor shrank tumors in one third of patients with incurable cancer related...
The University of Texas MD Anderson Cancer Center today joined with more than 450 communities and institutions across the country in hosting...
Padmanee Sharma, M.D., Ph.D., professor of Genitourinary Medical Oncology and Immunology at The University of Texas MD Anderson...
Researchers at The University of Texas MD Anderson Cancer Center have shown how BRCA-associated protein 1 (BAP1) serves as a tumor suppressor...
The University of Texas MD Anderson Cancer Center today was awarded $30 million to support research, core facilities, recruitment and prevention...
The University of Texas MD Anderson Cancer Center and Accelerator Life Science Partners, a leading life science investment and management...
Targeted cancer therapy pioneer John Mendelsohn, M.D., researcher and former president of The University of Texas MD Anderson Cancer Center...
A drug discovered and advanced by The University of Texas MD Anderson Cancer Center’s Institute for Applied Cancer Science (IACS) and TRACTION...
Clinical trials show that an immune checkpoint inhibitor shrinks the tumors of nearly half of patients with an incurable, advanced form of...
A new model for improving how clinical trials are developed and conducted by bringing together academic cancer experts and pharmaceutical...
Functional loss of ARID1a, a frequently mutated tumor suppressor gene, causes deficiencies in normal DNA repair and may sensitize tumors to...
The University of Texas MD Anderson Cancer Center and Spectrum Pharmaceuticals have signed a licensing agreement that covers discoveries by...
Colon polyps from patients with Lynch syndrome, a hereditary condition that raises colorectal cancer risk, display immune system activation...
The University of Texas MD Anderson Cancer Center today celebrated a milestone in the construction of its three-story clinic in The Woodlands...
The University of Texas MD Anderson Cancer Center and RaySearch Laboratories today announced a strategic alliance with the aim of enhancing...
The University of Texas MD Anderson Cancer Center was awarded $22.3 million from the Cancer Prevention and Research Institute of Texas...
A pair of targeted therapies given before and after surgery for melanoma produced at least a six-fold increase in time to progression compared...
Cancer immunotherapy innovator Jim Allison, Ph.D., chair of Immunology at The University of Texas MD Anderson Cancer Center, will receive...
The University of Texas MD Anderson Cancer Center and UT Health San Antonio applaud the actions of the San Antonio City Council today in voting...
Leaders of The University of Texas MD Anderson Cancer Center will head to Palm Beach Jan. 22 to present innovations in cancer research, treatment...
A new genetic-based model may explain how a common form of early-stage breast cancer known as ductal carcinoma in situ (DCIS) progresses to...